baber/WOPTO huggingface dataset:
Patent CA-2556383-A1 (CA)
Inventor: MERIZZI GIANFRANCO
IPC: A61P25/28
Filed: 2005-02-22
Abstract: The present invention relates to chemical compounds, to pharmaceutical and veterinary compositions, and to the use of such compositions for the treatment or prevention of neurodegenerative pathologies and syndromes, such as Parkinson's disease, Alzheimer's disease, lesions due to ischaemia and reperfusion, traumatic brain lesions, neuropathy due to HIV, Down's syndrome, diabetic polyneuropathy, muscular dystrophy, multiple sclerosis, Huntington's disease, prion disease, late dyskinesia, tauopathy and demyelinating pathologies, and other life-threatening pathologies such as cardiac/renal/pulmonary/hepatic/intestinal ischaemia-reperfusion, hypertension, diabetes, cancer, shock, toxicity due to drugs and radiation (radiotherapy and radiation protection), inflammatory conditions, atherosclerosis, aging, hyperlipidaemia, hypercholesterolaemia, epilepsy, and rheumatoid arthritis, all of which are known to be associated with an excess production of reactive free radicals. More particularly, the present invention relates to compositions containing antioxidant cyclic (bis)-hydroxylamines derived from N-piperidine as pharmaceutical compositions for the prevention and treatment of pathologies in man and in animals.
Patent CA-2556879-A1 (CA)
Title: Methods of preparation of an olefin oligomerization catalyst
Inventor: BARALT EDUARDO J
IPC: C07C2/32
Filed: 2005-02-18
Abstract: A method of making a catalyst for use in oligomerizing an olefin comprising a chromium-containing compound, a pyrrole-containing compound, a metal alkyl, a halide-containing compound, and optionally a solvent, the method comprising contacting a composition comprising the chromium-containing compound and a composition comprising the metal alkyl, wherein the composition comprising the chromium-containing compound is added to the composition comprising the metal alkyl.
Patent CA-2559369-A1 (CA)
Inventor: VOLMAR SCOTT M
IPC: G06Q20/00
Filed: 2005-04-12
Abstract: A method for secure data transactions over a computer network is described. In one embodiment, the act of generating at the first party a document, which authorizes the data transaction to proceed is performed. In one embodiment, the document content is signed using a computer network with audit-level encryption digital certificates. In one embodiment, a signed digital message (and/or document) is sent from the first party to the network transfer system electronically, and can be authenticated via the ICN certificate authorities to demonstrate the authorities of the signer of the signed document in assent to the transaction. In one embodiment, a copy of the signed digital document can be stored in a database associated with the transfer network system. In one embodiment, the system uses rules (patterns) of exchange agreed upon within and between organizations. These rules enable the exchange to progress smoothly and drive systematically the attention of participants to demands and problems etc. as a given transaction goes along.
Patent CA-2560131-A1 (CA)
Inventor: PARK JOHN EDWARD
IPC: A61P11/06
Filed: 2005-03-19
Abstract: The invention relates to the use of anticholinergic agents for producing a medicament for the prophylaxis and treatment of proliferative processes.
Patent CA-2563042-A1 (CA)
Title: 4-2-(cycloalkylamino)pyrimidin-4-yl-(phenyl)-imidazolin-2-one derivatives as p38 map-kinase inhibitors for the treatment of inflammatory diseases
Inventor: NAKAJIMA TATSUO
IPC: C07D405/14
Filed: 2005-04-28
Abstract: The present invention is to provide a novel heterocyclic compound of the formula [I]: wherein R1 is a halogen, nitro, an alkyl, etc.; R2 is hydrogen, an alkyl, etc.; Ring A is 2-oxo-4-imidazolin-3,4-diyl, etc.; Ring B is a cycloalkyl, monocyclic saturated heterocyclic group; X is CH, N; Y is a single bond, CO, SO2; Z is O, NH, etc.; and Ring C is an aryl, a heterocyclic group, or a pharmaceutically acceptable salt thereof, which is useful as a p38 MAP  kinase inhibitor.
Patent CA-2564348-A1 (CA)
Inventor: SMITH DAVID A
IPC: B62D25/22
Filed: 2006-10-17
Abstract: A bracket assembly secures a running board to a rocker panel, which includes a pinch weld depending therefrom. The bracket assembly includes a receiving panel adapted to have the running board fixedly secured thereto. A rocker securing plate extends out from the receiving panel and is secured to the rocker panel. An intermediate securing tab extends outwardly between the receiving panel and the rocker securing plate for securing the bracket assembly to the pinch weld outboard thereof.
Patent CA-2567342-A1 (CA)
Title: Aza-bicyclo[3.1.0]hex-1-yl derivatives active as nk1 antagonists
Inventor: WAGER TRAVIS T
IPC: C07D209/04
Filed: 2005-05-26
Abstract: The invention is to compounds exhibiting neurokinin inhibitory properties, pharmaceutical compositions comprising same and methods fo treatment for neurokinin-mediated conditions.
Patent CA-2569528-A1 (CA)
Title: Locking system for concrete form panels
Inventor: SPINDLER ROBERT A
IPC: E04G17/00
Filed: 2005-06-16
Abstract: A locking system (24) for securing adjacent concrete form panels (20a, 20b) together during assembly of a concrete form (22) is disclosed. The locking system (24) includes a mounting block (50) which is removably attachable to one of the adjacent panels (20a, 20b). A slide member (52) is mounted for sliding movement relative to the mounting block (50) between a first position retracted from aligned apertures (48) in side members (30) of the adjacent panels (20a, 20b) and a second position extending through the aligned apertures (48). The slide member (30) includes a bolt member (92) mounted to rotate within the mounting block (50) in its extended position between locked and unlocked positions to secure the adjacent panels (20a, 20b) together.  Alternatively, the bolt member (206) is configured to receive a wedge member (204) at its projecting end or has a clamping member (304) mounted to rotate on the bolt member (306) for securing the adjacent panels (20a, 20b) together.
Patent CA-2569561-A1 (CA)
Title: Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same
Inventor: VANCLEVE MARK DAVID
IPC: C12Q1/70
Filed: 2005-06-07
Abstract: Reagents, methods and immunodiagnostic test kits for the accurate detection of hepatitis B virus (HBV) infection are disclosed. The methods and kits employ novel rabbit monoclonal antibodies directed against HBV surface antigens (HBsAg) with mutations in the "a" determinant region of HBsAg.
Patent CA-2572231-A1 (CA)
Inventor: DRABOSENIG MANUELA
IPC: B63B59/02
Filed: 2005-06-30
Abstract: The invention relates to a ship fender used to protect the hull of a ship with fixing means enabling it to be fixed to the ship. The ship fender has a larger overall density than water. Preferably it comprises an inner area defined by an outer wall and at least two holes on opposite sides. Preferably, the fender is toroidal, the basic shape thereof being circular, oval or polygonal.
Patent CA-2574501-A1 (CA)
Inventor: SCHOFIELD RICHARD W
IPC: G06Q30/00
Filed: 2005-05-15
Abstract: A system and method for loading, transferring and redeeming value whereby two different systems of stored value accounts, one system being on a major network and the second system being on a secondary network, are linked, providing multiple paths to perform critical operations.
Patent CA-2575372-A1 (CA)
Title: Oral care implement
Inventor: WONG CHI SHING
IPC: B43K5/14
Filed: 2005-08-10
Abstract: An oral care implement with a handle includes a head with a releasable material (e.g., an oral medicament) and a tissue cleanser for cleaning the soft tissues and removing odor-causing bacteria from the mouth. In one arrangement, the releasable material is disposed on the surface of the tissue cleanser. In one arrangement, the releasable material is disposed behind the tissue cleanser. In one arrangement, the releasable material is incorporated in the composition of the tissue cleanser.
Patent CA-2576332-A1 (CA)
Title: Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists
Inventor: SCHLOTTER KARIN
IPC: A61P25/00
Filed: 2005-12-27
Abstract: The invention relates to annelated phenyl piperazine and phenyl diazepane carboxamides of general formula (I) containing oxygen.The compounds are suitable for medical purposes.
Patent CA-2576769-A1 (CA)
Title: High-visibility, flame resistant fabrics and methods for making same
Inventor: TUESDALE REMBERT J III
IPC: D06P3/82
Filed: 2005-08-05
Abstract: High-visibility, flame resistant fabrics and methods for making such fabrics.  In one embodiment, a high-visibility, flame resistant fabric includes a plurality of flame resistant cellulosic fibers, wherein the fabric has been dyed a high-visibility shade that complies with ANSI 107-1999.
Patent CA-2577591-A1 (CA)
Title: Procede de decoupe par faisceau laser
Inventor: SARDOU THIERRY
IPC: B23K26/38
Filed: 2007-02-08
Abstract: La présente invention porte sur un procédé de découpe d'au moins un premier ajour (53a) par faisceau laser dans une première plaque métallique (5) en présence d'une seconde plaque métallique (7) disposée parallèlement, à faible distance de la première plaque (5) et présentant un deuxième ajour (73a) dont le contour est au droit du contour de l'ajour (53a) à découper, caractérisé par le fait que l'on dispose entre les deux plaques (5 et 7) une plaque formant moyen de protection (10) d'épaisseur déterminée et présentant un troisième ajour (10a) de contour décalé vers l' intérieur par rapport au contour du deuxième ajour (73a).
Patent CA-2579990-A1 (CA)
Title: Higher than 30% concentration lime slurries, preparation and uses thereof
Inventor: BENSON ROBERT
IPC: C09K23/52
Filed: 2007-02-28
Abstract: The present invention relates to a composition comprising water, more than 30 % w/w of calcium hydroxide, and >= 0.2 % w/w dispersant. A process for preparing such a composition is also disclosed. The composition which can be in the form of a 45-55% concentration lime slurry is particularly useful for converting concentrated ammonium lignosulfonate into calcium lignosulfonate, for converting ammonium lignosulfonate into low sulfate calcium, potassium, sodium, or magnesium lignosulfonate and mixtures thereof, for removing soluble sulfate from concentrated sodium, potassium, ammonium or magnesium lignosulfonate or for treating a weak liquor obtained from the pulp and paper industry.
Patent CA-2582078-A1 (CA)
Inventor: HANSON JAMES S
IPC: B01D11/04
Filed: 2005-10-12
Abstract: A method and a system for obtaining bitumen from tar sand (10) are disclosed.  The disclosed method can include two extraction steps, such as a first extraction step (20) using a light aromatic solvent (15) and a second extraction step (75) using a volatile hydrocarbon solvent (60). The light aromatic solvent (15) and the volatile hydrocarbon solvent (60) both can be recycled (45) and (90) and used in multiple extractions. Each extraction and recycling step can include a separation (35) and (80). The disclosed system can include separators (35) and (80) configured to perform these separations.  Some of these separators also can function as mixers. Using the disclosed method and system, it is possible to achieve a high degree of bitumen recovery (40) and (85) while minimizing undesirable complications, such as swelling of clays in the tar sand and/or precipitation of asphaltenes.
Patent CA-2582977-A1 (CA)
Title: Method for central planning and distributed control of client roaming and reassociation
Inventor: BILSTAD ARNOLD
IPC: G06F7/00
Filed: 2005-09-12
Abstract: A technique for network planning that includes an interface for guiding a network user through the network allocation process, such as defining groups of clients based on their capabilities. Portions of the wireless local area network infrastructure, e.g., access points, are allocated among the groups.  When a client attempts to associate with an access point, the access point determines the client capabilities. If the client is supported by the access point, the access point allows the client to associate and sends the client a message that contains a prioritized list of other nearby access points allocated to service that client, otherwise the access point sends a prioritized roaming list of nearby access points to the client that are allocated to serve that type of client. Feedback is provided by the network infrastructure enabling a network user or the network to automatically reallocate resources based on the feedback.
Patent CA-2585183-A1 (CA)
Title: Improved method of electrochemical analysis of an analyte
Inventor: PURVIS DUNCAN ROSS
IPC: G01N27/416
Filed: 2005-11-10
Abstract: A method of electrochemical analysis using a sensor electrode specific for an analyte under test. The method comprises immersing the sensor electrode in a sample solution suspected of containing the analyte; forming an electrochemically active complex by exposure to solutions containing secondary receptors or competing molecules labelled with a charged or enzyme label; and subsequently exposing the sensor to an electrochemically active solution. The measurement step comprises driving the sensor electrode potential to a predetermined fixed potential by applying a current or activation waveform then monitoring the potential difference between the sensor electrode and a reference electrode following removal of the holding current. Current, rate and potential can all be measured and used to determine analyte concentration or sensor state.
Patent CA-2586889-A1 (CA)
Inventor: SATO SETSUO
IPC: C12P7/62
Filed: 2004-11-09
Abstract: The invention relates to a process for production of fatty acid es~ters directly from any soapstock generated in the alkali refining processes which contains 10-60% water, 0,1-2,0% of sterols, 35-85% of fatty derivatives including partial glycerides, by * neutralizing and splitting the soaps with strong acids until reaching pH 2-8 * followed by enzymatic esterification using Lipase with concentra~tion ranging from 100 ppm - 10% by weight, using C1 to C6 alkanol in a weight ratio of 5-100% in relation to the fatty components working at tem~perature from 15-70~C via batch or continuous processes . The invention also relates to the use of fatty acid esters produced according to the invention as biodiesel.
Patent CA-2587163-A1 (CA)
Title: Sidetrack option for monobore casing string
Inventor: GALLOWAY GREGORY G
IPC: E21B29/08
Filed: 2007-05-02
Abstract: Embodiments of the present invention provide apparatus and methods of forming a lateral wellbore wherein the monobore characteristic is maintained.  In one embodiment, a method of completing a lateral wellbore comprises inserting a first tubular into a main wellbore; forming one or more oversized portions on the first tubular; and intersecting the lateral wellbore with the main wellbore. The method further includes inserting a second tubular into the lateral wellbore, wherein a portion of the second tubular is positioned adjacent the one or more oversized portions and expanding the portion of the second tubular adjacent the one or more oversized portions.
Patent CA-2587722-A1 (CA)
Inventor: THELEN JOHN LOUIS
IPC: B62D33/04
Filed: 2007-05-04
Abstract: The present invention relates to a storage module having at least one exterior panel of a motorized vehicle, at least one door, and at least one inner panel.  The door is at least partially formed by at least one of the exterior panels. At least one of the exterior panels and at least one of the interior panels define at least one area to form the storage module.
Patent CA-2590226-A1 (CA)
Title: N-pyrrolidin-3yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors
Inventor: FISH PAUL VINCENT
IPC: C07D207/14
Filed: 2005-12-02
Abstract: A compound of Formula (I) and pharmaceutically and/or veterinarily acceptable derivatives thereof, wherein: R1 is H, C1-6alkyl, - C(A)D, C3-8cycloalkyl, aryl, het, aryl-C1-4alkyl or het-C1-4alkyl, wherein the cycloalkyl, aryl or het groups are optionally substituted; A is S or O; D is H, C1-6alkyl, aryl, het, aryl-C1-4alkyl or het-C1-4alkyl; aryl represents phenyl, naphthyl, anthracyl or phenanthryl; het represents an aromatic or non-aromatic 4-, 5~-or 6- membered heterocycle which contains at least one N, O or S heteroatom, optionally fused to a 5- or 6- membered carbocyclic group or a second 4-, 5-or 6-membered heterocycle which contains at least one N, O or S heteroatom; R2 is aryl1 or het1, each optionally substituted; n is 1 or 2, provided that when n is 1, m is 0 or 1 and when n is 2, m is 0, wherein if m is 0, then *  represents a chiral centre; R3 is (CH2)aE, wherein a is 0, 1 or 2 and E is a group selected from: Formula (i) wherein: X is O, S, NR12, (CH2)v or a bond; b is 1, 2, 3 or 4; c is 1, 2 or 3; v is 1 or 2; R10 and 11 are each independently H or C1-4 alkyl; and R12 is H, 1-6 alkyl, C(O)C1-6 alkyl, SO2-C1-6alkyl; and wherein one or more pairs of hydrogen atoms on adjacent carbon or nitrogen atoms may be replaced by a corresponding number of double bonds, provided the ring system is not aromatic; Formula (ii) a carbocyclic spiro group containing 6 to 12 carbon atoms; Formula (iii) wherein: d is 1, 2, 3 or 4; a is 1, 2 or 3; f is 1 or 2; and R30 is H or C14 alkyl; and wherein one or more pairs of hydrogen atoms on adjacent carbon atoms may be replaced by a corresponding number of double bonds, provided the ring system is not aromatic; Formula (iv) wherein: g is 0, 1, 2 or 3; J is NR40; and R40 is C(O)C1-6 alkyl, S02-C1-6 alkyl; Formula (v) wherein: h is 0, 1, 2 or 3; and R50 is H, C1-8alkyl, C1-8alkoxy, OH, halo, CF3, OCF3, SCF3, hydroxy-C1-6alkyl, C1-4alkoxy-C1-6alkyl and C1-4alkyl-S-C1-4alkyl; Formula (vi) -CH(cyclopropane)2; Formula (vii) C1-6alkyl, substituted by at least one substituent; and Formula (viii) C3-8cycloalkyl-C1-6alkyl; wherein the C1-6alkyl moiety is substituted at any point other than at the junction with the C3-8cycloalkyl moiety, by at least one substituent. The compounds exhibit activity as both serotonin and/or noradrenaline re-uptake inhibitors and therefore have utility in a variety of therapeutic areas, for example urinary incontinence.
Patent CA-2592308-A1 (CA)
Inventor: KYO KOUBUN
IPC: G01F1/00
Filed: 2005-12-27
Abstract: Dans le but de réaliser très simplement une évaluation quantitative de la quantité effective en circulation d'une matière formant lit et d'améliorer la précision de la comparaison des résultats du bilan thermique obtenus par simulation aux résultats pratiques, le temps mis par la matière formant lit déposée dans un déversoir (5) pour atteindre une hauteur supérieure prédéterminée H1 à partir d'une hauteur inférieure prédéterminée H0 est mesurée après interruption de l'alimentation d'un échangeur de chaleur externe (7) en air fluidisant, et le débit de la matière formant lit est ensuite déterminé comme la quantité en circulation à partir de ce temps et de la quantité de matière formant lit déposée, en fonction du diamètre intérieur D du déversoir (5).
Patent CA-2594186-A1 (CA)
Inventor: CHONG SE YOUNG
IPC: A61K31/366
Filed: 1999-10-21
Abstract: This invention relates to a cancer-cell differentiation induction agent composition, especially human leukemia cell differentiation composition containing decursin as an active ingredient and a pharmaceutically acceptable carrier.
Patent CA-2595423-A1 (CA)
Title: Product authenticity validation system
Inventor: VANJANI GOVIND W
IPC: G06K9/00
Filed: 2006-01-20
Abstract: A method, system and apparatus for verifying the authenticity of a product are described. A verification center is maintained which can communicate with a database. A verification number or device card is supplied to a consumer in association with a product whose authenticity is to be verified. The consumer can contact the verification center and convey a unique identifier. Records stored in the database are checked to determine if the unique identifier is genuine and if the unique identifier has been previously conveyed. If the unique identifier is not genuine or has been previously conveyed, the consumer is informed that the product may be counterfeit. If the unique identifier is genuine and has not been previously conveyed, the consumer is informed that the product is authentic and record is made in the database indicating that the unique identifier has been conveyed.
Patent CA-2595584-A1 (CA)
Title: Multiple needle injection catheter and method of use of same
Inventor: PALASIS MARIA
IPC: A61M25/00
Filed: 2005-12-22
Abstract: Embodiments of the present invention relate to multiple needle catheter-based injection systems to deliver a plug of a therapeutic or other agent. A medical device may include a catheter with a distal end, a proximal end and a catheter lumen extending there between and an outer needle disposed in the catheter lumen with a distal end and a proximal end and an outer needle, lumen extending there between. The medical device may include an inner needle with a distal end and a proximal end, the inner needle being disposed in the outer needle lumen and the distal end of the inner needle to receive and hold a therapeutic plug, and a needle control mechanism coupled to the proximal ends of the outer needle and the inner needle, the needle control mechanism to independently and jointly control ejection and retraction of the outer and inner needles to deliver the therapeutic plug into a target tissue site.
Patent CA-2596394-A1 (CA)
Inventor: SCHAUG-PETTERSEN TOR
IPC: G01V3/30
Filed: 2006-01-27
Abstract: Multifrequency electromagnetic signals which may be used in the field of sea bed logging, the signal being optimised for use at a particular site, in order to greatly improve data inversion, and a method for producing the optimum multifrequency signal.
Patent CA-2599417-A1 (CA)
Inventor: BAILEY RONALD E
IPC: C22C38/12
Filed: 2006-08-29
Abstract: Maraging steel compositions, methods of forming the same, and articles formed therefrom comprising, by weight, 15.0 to 20.0% Ni, 2.0 to 6.0% Mo, 3.0 to 8.0%  Ti, up to 0.5% Al, the balance Fe and residual impurities. The composition may be a first layer of a composite plate, and may have a second layer deposited on the first layer, the second layer having a composition comprising, by weight, 15.0 to 20.0% Ni, 2.0 to 6.0% Mo, 1.0 to 3.0 Ti, up to 0.5% Al, the balance Fe and residual impurities. The first layer may have a hardness value ranging from 58 to 64 RC, and the second layer may have a hardness value ranging from 48 to 54 RC. The first layer may be formed employing powdered metallurgical techniques. Articles formed from the compositions include armored plate.
Patent CA-2599495-A1 (CA)
Title: Folded fibrous structures
Inventor: FORDE-KOHLER LOIS JEAN
IPC: A47K10/38
Filed: 2006-02-08
Abstract: Folded fibrous structures, more particularly, folded sanitary tissue products, especially in rolled form, are provided.
Patent CA-2601320-A1 (CA)
Title: Layered web sealing and severing head and method for use thereof
Inventor: TOBOLKA STEFAN
IPC: B65B51/30
Filed: 2005-02-03
Abstract: A sealing assembly is employed to clamp together layers of a layered web, such as two layers of flexible laminate plastic film, and to bond and cut the layers by applying heat and pressure. The sealing assembly may include a pair of jaws, one of which has a sealing head with a conductive knife protruding from a tapered dielectric supporting base. The knife has a high thermal conductivity relative to the supporting base. A current supplied through the knife heats it and the heat of the knife raises the temperature of the supporting base to a baseline temperature. When the head abuts the layered web, a spike current through the knife raises its temperature momentarily to melt through, and therefore sever, the web.